Ampio Pharmaceuticals’ Vyrix files registration statement for proposed IPO
Ampio announced its subsidiary Vyrix Pharmaceuticals has filed a registration statement on Form S-1 with the SEC relating to the proposed initial public offering of its common stock. All of the shares to be sold in the proposed offering will be offered by Vyrix. April 21, 2014